Albuminuria, Proteinuria, and Renal Disease Progression in Children with CKD

被引:57
作者
Fuhrman, Dana Y.
Schneider, Michael F.
Dell, Katherine M.
Blydt-Hansen, Tom D.
Mak, Robert
Saland, Jeffrey M.
Furth, Susan L.
Warady, Bradley A.
Moxey-Mims, Marva M.
Schwartz, George J.
机构
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2017年 / 12卷 / 06期
关键词
CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; COLLABORATIVE METAANALYSIS; HIGH-RISK; CARDIOVASCULAR EVENTS; URINARY ALBUMIN; EXCRETION RATE; ALL-CAUSE; MICROALBUMINURIA; PREDICTORS;
D O I
10.2215/CJN.11971116
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives The role of albuminuria as an indicator of progression has not been investigated in children with CKD in the absence of diabetes. Design, setting, participants, & measurements Children were enrolled from 49 centers of the CKD in Children study between January of 2005 and March of 2014. Cross-sectional multivariable linear regression (n=647) was used to examine the relationship between urine protein-to-creatinine (UP/C [milligrams per milligram]) and albumin-to-creatinine (ACR [milligrams per gram]) with eGFR (milliliters per minute per 1.73 m(2)). Parametric time-to-event analysis (n=751) was used to assess the association of UP/C, ACR, and urine nonalbumin-tocreatinine (Unon-alb/cr [milligrams per gram]) on the time to the composite endpoint of initiation of RRT or 50% decline in eGFR. Results The median follow-up time was 3.4 years and 202 individuals experienced the event. Participants with a UP/C >= 0.2 mg/mg and ACR >= 30 mg/g had a mean eGFR that was 16 ml/min per 1.73 m2 lower than those with a UP/C<0.2 mg/mg and ACR<30 mg/g. Individuals with ACR<30 mg/g, but a UP/C >= 0.2 mg/mg, had a mean eGFR that was 9.3 ml/min per 1.73 m2 lower than those with a UP/C<0.2 mg/mg. and ACR<30 mg/g. When categories of ACR and Unon-alb/cr were created on the basis of clinically meaningful cutoff values of UP/C with the same sample sizes for comparison, the relative times (RTs) to the composite end-point were almost identical when comparing the middle (RT=0.31 for UP/C [0.2-2.0 mg/mg], RT=0.38 for ACR [56-1333 mg/g], RT=0.31 for Unon-alb/cr [118-715 mg/g]) and the highest (RT=0.08 for UP/C [>2.0 mg/mg], RT=0.09 for ACR [>1333 mg/g], RT=0.07 for Unon-alb/cr [>715 mg/g]) levels to the lowest levels. A similar trend was seen when categories were created on the basis of clinically meaningful cutoff values of ACR (<30, 30-300, >300 mg/g). Conclusions In children with CKD without diabetes, the utility of an initial UP/C, ACR, and Unon-alb/cr for characterizing progression is similar.
引用
收藏
页码:912 / 920
页数:9
相关论文
共 50 条
  • [41] Improvement of albuminuria after renal denervation
    Ott, Christian
    Mahfoud, Felix
    Schmid, Axel
    Ditting, Tilmann
    Veelken, Roland
    Ewen, Sebastian
    Ukena, Christian
    Uder, Michael
    Boehm, Michael
    Schmieder, Roland E.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 173 (02) : 311 - 315
  • [42] Evaluation of Urinary Indices for Albuminuria and Proteinuria in Patients with Chronic Kidney Disease
    Hong, Dennis Sung Chul
    Oh, Il Hwan
    Park, Joon-Sung
    Lee, Chang Hwa
    Kang, Chong Myung
    Kim, Gheun-Ho
    KIDNEY & BLOOD PRESSURE RESEARCH, 2016, 41 (03) : 258 - 266
  • [43] Plasma Copeptin and Renal Outcomes in Patients With Type 2 Diabetes and Albuminuria
    Velho, Gilberto
    Bouby, Nadine
    Hadjadj, Samy
    Matallah, Nadia
    Mohammedi, Kamel
    Fumeron, Frederic
    Potier, Louis
    Bellili-Munoz, Naima
    Taveau, Christopher
    Alhenc-Gelas, Francois
    Bankir, Lise
    Marre, Michel
    Roussel, Ronan
    DIABETES CARE, 2013, 36 (11) : 3639 - 3645
  • [44] IMPLICATION OF PROTEINURIA IN THE DIAGNOSIS AND MONITORING OF THE CHRONIC KIDNEY DISEASE (CKD)
    Alegre, Jorge R.
    Alles, Alberto
    Angerosa, Margarita
    Eugenia Bianchi, Maria
    Dorado, Enrique
    Cecilia Etchegoyen, Maria
    Fayad, Alicia
    Greloni, Gustavo
    Inserra, Felipe
    Mazziotta, Daniel
    Pennacchiotti, Graciela
    Rosa Diez, Guillermo
    Torales, Santiago
    Lia Torres, Maria
    Varela, Federico
    Villagra, Alberto
    REVISTA DE NEFROLOGIA DIALISIS Y TRASPLANTE, 2013, 33 (04): : 233 - 248
  • [45] Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure
    Haas, Mary E.
    Aragam, Krishna G.
    Emdin, Connor A.
    Bick, Alexander G.
    Hemani, Gibran
    Smith, George Davey
    Kathiresan, Sekar
    AMERICAN JOURNAL OF HUMAN GENETICS, 2018, 103 (04) : 461 - 473
  • [46] Therapeutic efficacy of pentoxifylline on proteinuria and renal progression: an update
    Chen, Yung-Ming
    Chiang, Wen-Chih
    Lin, Shuei-Liong
    Tsai, Tun-Jun
    JOURNAL OF BIOMEDICAL SCIENCE, 2017, 24
  • [47] Association of Income Level With Kidney Disease Severity and Progression Among Children and Adolescents With CKD: A Report From the Chronic Kidney Disease in Children (CKiD) Study
    Hidalgo, Guillermo
    Ng, Derek K.
    Moxey-Mims, Marva
    Minnick, Maria Lourdes
    Blydt-Hansen, Tom
    Warady, Bradley A.
    Furth, Susan L.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2013, 62 (06) : 1087 - 1094
  • [48] Prevention of Chronic kidney disease (CKD) in children
    Carmine Pecoraro
    Italian Journal of Pediatrics, 41 (Suppl 2)
  • [49] Albuminuria: When urine predicts kidney and cardiovascular disease
    Stephen, Reejis
    Jolly, Stacey E.
    Nally, Joseph V.
    Navaneethan, Sankar D.
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2014, 81 (01) : 41 - 50
  • [50] Current drug development challenges in chronic kidney disease (CKD)-identification of individualized determinants of renal progression and premature cardiovascular disease (CVD)
    Formentini, Ivan
    Bobadilla, Maria
    Haefliger, Carolina
    Hartmann, Guido
    Loghman-Adham, Mahmoud
    Mizrahi, Jacques
    Pomposiello, Silvia
    Prunotto, Marco
    Meier, Matthias
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 81 - 88